Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_3882E44472F2
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study.
Journal
Annals of the rheumatic diseases
Author(s)
Bettiol A., Urban M.L., Bello F., Fiori D., Mattioli I., Lopalco G., Iannone F., Egan A., Dagna L., Caminati M., Negrini S., Bargagli E., Folci M., Franceschini F., Padoan R., Flossmann O., Solans R., Schroeder J., André M., Moi L., Parronchi P., Roccatello D., Sciascia S., Jayne D., Prisco D., Vaglio A., Emmi G.
Working group(s)
European EGPA Study Group
Contributor(s)
Cameli P., Conti F., Fagni F., Losappio L., Malandrino D., Mazzetti M., Mazzotta R., Moroni L., Palermo A., Ribi C., Schiavon F., Silvestri E., Terrier B., Toniati P.
ISSN
1468-2060 (Electronic)
ISSN-L
0003-4967
Publication state
Published
Issued date
12/2022
Peer-reviewed
Oui
Volume
81
Number
12
Pages
1769-1772
Language
english
Notes
Publication types: Observational Study ; Multicenter Study ; Journal Article
Publication Status: ppublish
Keywords
Humans, Rituximab/therapeutic use, Churg-Strauss Syndrome/drug therapy, Granulomatosis with Polyangiitis/drug therapy, Antibodies, Monoclonal, Humanized/therapeutic use, Biological Therapy, Epidemiology, Rituximab, Systemic vasculitis
OAI-PMH
oai:serval.unil.ch:BIB_3882E44472F2
DOI
10.1136/ard-2022-222776
Pubmed
35850947
Web of science
000827648600001
Create date
26/07/2022 13:31
Last modification date
16/09/2023 6:54
Usage data